Finance

Lists
036480:KOSDAQ
Daesung Microbiological Labs, Co., Ltd.
₩5,860.00
+1.21%
(+70.00) 1D
Oct 19, 3:30:00 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 036480...
Open
₩5,720
High
₩5,930
Low
₩5,710
Mkt. cap
22.27B
Avg. vol.
3.94K
Volume
3.65K
Dividend
1.28%
Quarterly dividend
₩19
Ex-dividend date
Dec 27, 2024
P/E ratio
63.48
52-wk high
₩10,960
52-wk low
₩5,400
EPS
₩92
Shares outstanding
3.80M
No. of employees
137
Open
₩5,720
High
₩5,930
Low
₩5,710
Mkt. cap
22.27B
Avg. vol.
3.94K
Volume
3.65K
Dividend
1.28%
Quarterly dividend
₩19
Ex-dividend date
Dec 27, 2024
P/E ratio
63.48
52-wk high
₩10,960
52-wk low
₩5,400
EPS
₩92
Shares outstanding
3.80M
No. of employees
137
News stories
From web sources and news partners
About Daesung Microbiological Labs, Co., Ltd.
CEO-
Employees137
Founded1966
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.18B
6.92B
5.08B
6.01B
Cost of goods sold
5.28B
5.52B
4.12B
5.33B
Cost of revenue
5.28B
5.52B
4.12B
5.33B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.31B
1.44B
1.19B
1.07B
Operating expense
1.31B
1.67B
1.47B
1.16B
Total operating expenses
6.59B
7.19B
5.60B
6.48B
Operating income
590.74M
-269.69M
-515.79M
-472.21M
Other non operating income
103.75M
33.43M
6.39M
8.95K
EBT including unusual items
694.49M
-253.44M
-258.74M
-386.30M
EBT excluding unusual items
694.49M
-253.42M
-260.67M
-398.43M
Income tax expense
-58.14M
-496.63M
-50.33M
50.33M
Effective tax rate
-8.37%
195.95%
19.45%
-13.03%
Other operating expenses
-
21.01M
22.64M
21.54M
Net income
752.64M
243.19M
-208.41M
-436.63M
Net profit margin
10.48%
3.52%
-4.10%
-7.26%
Earnings per share
-
-
-
-
Interest and investment income
-
58.77M
60.84M
65.37M
Interest expense
-
-148.63M
-145.55M
-143.59M
Net interest expenses
-
-89.86M
-84.71M
-78.22M
Depreciation and amortization charges
-
82.03M
79.95M
75.26M
EBITDA
1.22B
363.04M
113.18M
153.98M
Gain or loss from assets sale
-
-
-1.95M
-12.27M
AI content may include mistakes. Learn more
Google apps